Northern Africa and Western Asia vs Sri Lanka: Proportion of the target population who received
Northern Africa and Western Asia
78.0%
in 2024
Sri Lanka
98.0%
in 2024
Northern Africa and Western Asia rank
19th
Sri Lanka rank
17th
Proportion of the target population who received over time
- Northern Africa and Western Asia
- Sri Lanka
How they compare
Sri Lanka currently reports 98.0% against 78.0% in Northern Africa and Western Asia, a difference of 20.0%.
That makes Sri Lanka's figure about 1.3 times Northern Africa and Western Asia's.
The two have swapped places 1 time across 24 shared years of data; in 2001 it was Northern Africa and Western Asia ahead.
Northern Africa and Western Asia ranks 19th and Sri Lanka ranks 17th of 37 groups.
Sri Lanka has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Northern Africa and Western Asia | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.3% | 90.8% | 24.4% | Sri Lanka |
| 2010s | 77.5% | 99.0% | 21.5% | Sri Lanka |
| 2020s | 80.0% | 97.6% | 17.6% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Northern Africa and Western Asia or Sri Lanka?
- Sri Lanka, at 98.0% against 78.0% in Northern Africa and Western Asia as of 2024.
- What is the difference in proportion of the target population who received between Northern Africa and Western Asia and Sri Lanka?
- 20.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Northern Africa and Western Asia and Sri Lanka?
- 24 years are reported by both, from 2001 to 2024.
- How do Northern Africa and Western Asia and Sri Lanka rank globally for proportion of the target population who received?
- Northern Africa and Western Asia ranks 19th and Sri Lanka ranks 17th of 37 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.